CE Information – Test v8 copy 1
A Closer Look at the Association of Alcohol Intake With Hypertension in Type 2 Diabetes
Release: 04/16/2021 Expiration: 04/16/2022
Target Audience
This activity is designed for an audience of Physicians, Nurses, and Physician Assistants
Learning Objectives
Upon completion of the educational activity, participants should be able to:
- Discuss a study that explored the relationship between various levels of alcohol consumption and the risk of hypertension in patients with diabetes.
Criteria for Success
To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at dcotterman@akhcme.com
Credit provided by AKH Inc., Advancing Knowledge in Healthcare
“In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Physician’s Weekly. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.”
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
0.5 ANCC contact hours
AAPA Credit Designation Statement
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until 04/16/2022. PAs should only claim credit commensurate with the extent of their participation.
Commercial Support
: –
There is no commercial support for this activity.
Disclosure
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
| Disclosures | ||
| NAME | RELATIONSHIP | COMPANY |
| Chris Cole – Editorial Director Physician’s Weekly |
N/A | Nothing to Disclose |
| Matthew Singleton, MD, MBE, MHS, MSc. | N/A | Nothing to disclose |
| Dorothy Caputo, MA, BSN, RN VP, Continuing Education & Compliance Bernadette Marie Makar, MSN, APRN, BC, NP-C |
N/A | Nothing to disclose |
| Physician’s Weekly Planners and Reviewers | N/A | Nothing to disclose |
| AKH Planners and Reviewers | N/A | Nothing to disclose |
| All of the relevant financial relationships listed for these individuals have been mitigated. | ||
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.Disclosure of Unlabeled Use and Investigational Product.
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.